Element Capital Management LLC Boosts Position in HCA Healthcare, Inc. $HCA

Element Capital Management LLC grew its stake in HCA Healthcare, Inc. (NYSE:HCA) by 62.8% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 19,427 shares of the company’s stock after buying an additional 7,493 shares during the quarter. HCA Healthcare makes up approximately 4.3% of Element Capital Management LLC’s portfolio, making the stock its 7th biggest position. Element Capital Management LLC’s holdings in HCA Healthcare were worth $9,070,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. Nordea Investment Management AB boosted its holdings in shares of HCA Healthcare by 11.2% in the 4th quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock worth $507,393,000 after purchasing an additional 108,849 shares in the last quarter. Hudson Bay Capital Management LP boosted its stake in HCA Healthcare by 154.5% in the third quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company’s stock worth $2,000,000 after buying an additional 2,849 shares in the last quarter. Nomura Asset Management Co. Ltd. raised its stake in shares of HCA Healthcare by 6.2% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock worth $29,990,000 after acquiring an additional 3,724 shares in the last quarter. Advisors Capital Management LLC boosted its stake in shares of HCA Healthcare by 61.5% in the 4th quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock valued at $3,192,000 after purchasing an additional 2,604 shares in the last quarter. Finally, CWA Asset Management Group LLC lifted its stake in HCA Healthcare by 1,062.4% in the fourth quarter. CWA Asset Management Group LLC now owns 9,555 shares of the company’s stock worth $4,461,000 after purchasing an additional 8,733 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 2.3%

Shares of HCA opened at $387.87 on Thursday. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52. The firm has a market capitalization of $86.05 billion, a price-to-earnings ratio of 13.34, a PEG ratio of 1.26 and a beta of 1.12. The firm’s 50-day moving average price is $424.54 and its 200-day moving average price is $470.67.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The firm had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm’s revenue was up 4.3% on a year-over-year basis. During the same quarter last year, the company posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s payout ratio is 10.73%.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Wall Street Zen downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. JPMorgan Chase & Co. decreased their price target on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 19th. Oppenheimer dropped their price objective on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Mizuho upped their price target on shares of HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a report on Wednesday, February 25th. Finally, Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a research report on Wednesday, March 4th. Fifteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $506.14.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.